These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20564207)

  • 1. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
    Yan L; Huang H; Tang QZ; Zhu LH; Wang L; Liu C; Bian ZY; Li H
    J Cell Biochem; 2010 Apr; 109(6):1158-71. PubMed ID: 20127712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
    Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
    J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
    Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
    Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
    Liu L; Zhao X; Pierre SV; Askari A
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.
    Liu C; Cao F; Tang QZ; Yan L; Dong YG; Zhu LH; Wang L; Bian ZY; Li H
    J Nutr Biochem; 2010 Dec; 21(12):1238-50. PubMed ID: 20185286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA; O'Connell TD; Gerdes AM
    Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.
    Honda Y; Shishido T; Takahashi T; Watanabe T; Netsu S; Kinoshita D; Narumi T; Kadowaki S; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Kishida S; Kadomatsu K; Takeishi Y; Kubota I
    Hypertension; 2016 May; 67(5):857-65. PubMed ID: 26975703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
    Zhang Y; Shang Z; Liu A
    Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.
    Cai J; Yi FF; Yang L; Shen DF; Yang Q; Li A; Ghosh AK; Bian ZY; Yan L; Tang QZ; Li H; Yang XC
    Hypertension; 2009 Mar; 53(3):539-48. PubMed ID: 19204184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.
    Ma ZG; Yuan YP; Zhang X; Xu SC; Wang SS; Tang QZ
    EBioMedicine; 2017 Apr; 18():179-187. PubMed ID: 28330809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
    Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
    Peng K; Tian X; Qian Y; Skibba M; Zou C; Liu Z; Wang J; Xu Z; Li X; Liang G
    J Cell Mol Med; 2016 Mar; 20(3):482-94. PubMed ID: 26762600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2015 Aug; 19(8):1929-38. PubMed ID: 25946687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure.
    Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH
    Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.